The Salter Group is a leading independent financial and strategic advisory firm that specializes in providing the following services for biotechnology, pharmaceutical and medical device companies from early stage, middle market and Fortune 500 companies and capital market constituents.

• Forecast Assessment & Development Services – company, product and portfolio forecast
  assessment or development services utilizing primary and secondary market research
• Financial Opinions – fairness, solvency and other transaction opinions
• Valuation Opinions – fund-portfolio NAV, goodwill impairment, purchase price allocation,
  equity incentives, estate & gift tax and other purposes
• Transaction Support Services – debt-finance and royalty-securitizations, licensing agreements,
  equity investments and M&A transactions

With the benefit of over 300 projects for life science companies representing over $6 billion in asset and business values completed in the past three years by our professional staff, and more than 850 projects across other industry sectors representing over $90 billion in values completed since our 2003 inception, The Salter Group has the requisite credentials and real world transactional experience to deliver superior results for our clients.

Our extensive experience in developing life science product, portfolio and business forecasts and associated value indications enhances the strength of our transaction opinions, financial opinions, tax-related opinions, financial and strategic analysis, and transaction support for parties seeking greater insight and comfort than is often provided by competing firms.

The Salter Group is not an investment bank, and therefore has no inherent conflicts of interest. This objectivity empowers the executive officers, boards of directors, independent committees, investment banks, capital providers and professional advisors we advise in any transactional or advisory setting. For more information, please visit our website at www.saltergroup.com.

For questions and inquiries, please contact: Samuel L. Renwick at 925.942.0373 or srenwick@saltergroup.com or Roy A. Salter at 310.552.3774 or rsalter@saltergroup.com